These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
112 related articles for article (PubMed ID: 766612)
1. Pathogenesis and therapy of neonatal graves disease. Fisher DA Am J Dis Child; 1976 Feb; 130(2):133-4. PubMed ID: 766612 [No Abstract] [Full Text] [Related]
2. [LATS-the extrapituitary thyroid stimulator and its role in the etiology and pathogenesis of Graves-Basedow disease]. Nauman J; Nauman A Pol Arch Med Wewn; 1969 Oct; 43(4):1427-32. PubMed ID: 5395131 [No Abstract] [Full Text] [Related]
6. The long-acting thyroid stimulatory: is it of importance in Graves' disease. McKenzie JM; Zakarija M; D'Amour P; Joasoo A N Z Med J; 1975 Jan; 81(531):18-21. PubMed ID: 165442 [No Abstract] [Full Text] [Related]
7. Thyroid stimulating immunoglobulins. The Watson Smith lecture 1983. Munro DS J R Coll Physicians Lond; 1984 Jul; 18(3):155-60. PubMed ID: 6147408 [No Abstract] [Full Text] [Related]
8. The immunologic basis of Graves's disease. Volpé R N Engl J Med; 1972 Aug; 287(9):463-4. PubMed ID: 5068098 [No Abstract] [Full Text] [Related]
9. Current concepts in management of thyroid disease. DeGroot LJ Med Clin North Am; 1970 Jan; 54(1):117-30. PubMed ID: 4189143 [No Abstract] [Full Text] [Related]
10. Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease. Pittman JG; Maloof F Am J Med Sci; 1972 Dec; 264(6):499-505. PubMed ID: 4119609 [No Abstract] [Full Text] [Related]
12. Long-acting thyroid stimulator and related factors. Kendall-Taylor P; Dirmikis SM; Munro DS Proc R Soc Med; 1975 Apr; 68(4):252-3. PubMed ID: 1242809 [No Abstract] [Full Text] [Related]
13. Immunological studies of the eye changes of thyrotoxicosis. Wall JR; Odgers R; Hetzel BS Aust N Z J Med; 1973 Apr; 3(2):162-8. PubMed ID: 4515114 [No Abstract] [Full Text] [Related]
14. Ophthalmic Graves' disease. Diagnosis and pathogenesis. Hall R; Kirkham K; Doniach D; el-Kabir D Lancet; 1970 Feb; 1(7643):375-8. PubMed ID: 4189686 [No Abstract] [Full Text] [Related]
15. [LATS and other thyroid-stimulating immunoglobulins in the pathogenesis of Basedow's disease]. Pinchera A; Baschieri L Recenti Prog Med; 1976 Dec; 61(6):790-823. PubMed ID: 1037332 [No Abstract] [Full Text] [Related]
16. The role of long-acting thyroid stimulator and of thyroid autoimmunity in the pathogenesis of euthyroid endocrine ophthalmopathy. Földes J; Takó J; Bános C; Gesztesi E Acta Med Acad Sci Hung; 1971; 28(2):171-9. PubMed ID: 5172524 [No Abstract] [Full Text] [Related]
17. Clinical applications of assays for thyrotropin-receptor antibodies in Graves' disease. Ginsberg J; von Westarp C CMAJ; 1986 May; 134(10):1141-7. PubMed ID: 2421862 [TBL] [Abstract][Full Text] [Related]
19. [Thyroid stimulating immunoglobulins, their role and significance in the pathogenesis of Basedow-Graves disease]. Leövey A Orv Hetil; 1978 Aug; 119(33):2019-21. PubMed ID: 209384 [No Abstract] [Full Text] [Related]
20. Mechanisms of Graves' disease and endocrine exophthalmos. Anderson DR Am J Ophthalmol; 1969 Jul; 68(1):46-57. PubMed ID: 4895778 [No Abstract] [Full Text] [Related] [Next] [New Search]